LSC Webinars CELL All

  1. Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation 10/22/2025

    Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.

  2. Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches 10/22/2025

    Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.

  3. Development Of An Off-The-Shelf γδ T-Cell Platform 10/20/2025

    Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.

  4. Evolving Gene Editing For Rare Disease Drug Development 10/9/2025

    Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.

  5. Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing 10/9/2025

    Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.

  6. Supply Resiliency For Bioprocessing Amid Global Volatility 10/2/2025

    Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

  7. Achieving Flexibility In T Cell Manufacturing - Adaptation Of Standardized Processes 10/2/2025

    Explore how scalable CAR-T manufacturing impacts T cell biology and therapy efficacy, as well as how standardized processes can support diverse production needs while preserving critical characteristics.

  8. Genetically Modified MSCs For The Treatment Of GvHD 9/30/2025

    Discover how genetically engineered MSCs are significantly advancing GvHD treatment. Learn about preclinical success with CXCR4-IL10-MSCs and the process for scaling up their GMP production.

  9. Avoid The Wrecking Ball: Targeted Solutions For Struggling Trials 9/30/2025

    In this presentation, our expert panel introduces the concept of scaffolding — a targeted reinforcement strategy designed to strengthen trials from the inside out.

  10. Filtration Unfiltered: Technology To Meet New Bioprocessing Challenges 9/29/2025

    Explore how filtration strategies are adapting to diverse molecule pipelines, regulations, and sustainability targets with insights into process intensification and the technologies shaping the future.